136 related articles for article (PubMed ID: 7578395)
1. Cancer gene therapy using plasmid DNA: safety evaluation in rodents and non-human primates.
Parker SE; Vahlsing HL; Serfilippi LM; Franklin CL; Doh SG; Gromkowski SH; Lew D; Manthorpe M; Norman J
Hum Gene Ther; 1995 May; 6(5):575-90. PubMed ID: 7578395
[TBL] [Abstract][Full Text] [Related]
2. Tissue distribution of the cytofectin component of a plasmid-DNA/cationic lipid complex following intravenous administration in mice.
Parker SE; Ducharme S; Norman J; Wheeler CJ
Hum Gene Ther; 1997 Mar; 8(4):393-401. PubMed ID: 9054514
[TBL] [Abstract][Full Text] [Related]
3. Cancer gene therapy using plasmid DNA: purification of DNA for human clinical trials.
Horn NA; Meek JA; Budahazi G; Marquet M
Hum Gene Ther; 1995 May; 6(5):565-73. PubMed ID: 7578394
[TBL] [Abstract][Full Text] [Related]
4. Phase I study of direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7, in patients with metastatic melanoma.
Stopeck AT; Hersh EM; Akporiaye ET; Harris DT; Grogan T; Unger E; Warneke J; Schluter SF; Stahl S
J Clin Oncol; 1997 Jan; 15(1):341-9. PubMed ID: 8996161
[TBL] [Abstract][Full Text] [Related]
5. Human gene therapy for melanoma: CT-guided interstitial injection.
Waddill W; Wright W; Unger E; Stopeck A; Akporiaye E; Harris D; Grogan T; Schluter S; Hersh E; Stahl S
AJR Am J Roentgenol; 1997 Jul; 169(1):63-7. PubMed ID: 9207502
[TBL] [Abstract][Full Text] [Related]
6. Cancer gene therapy using plasmid DNA: pharmacokinetic study of DNA following injection in mice.
Lew D; Parker SE; Latimer T; Abai AM; Kuwahara-Rundell A; Doh SG; Yang ZY; Laface D; Gromkowski SH; Nabel GJ
Hum Gene Ther; 1995 May; 6(5):553-64. PubMed ID: 7578393
[TBL] [Abstract][Full Text] [Related]
7. Phase I study of immunotherapy of hepatic metastases of colorectal carcinoma by direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7.
Rubin J; Galanis E; Pitot HC; Richardson RL; Burch PA; Charboneau JW; Reading CC; Lewis BD; Stahl S; Akporiaye ET; Harris DT
Gene Ther; 1997 May; 4(5):419-25. PubMed ID: 9274718
[TBL] [Abstract][Full Text] [Related]
8. Phase I study of direct intralesional gene transfer of HLA-B7 into metastatic renal carcinoma lesions.
Rini BI; Selk LM; Vogelzang NJ
Clin Cancer Res; 1999 Oct; 5(10):2766-72. PubMed ID: 10537340
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of HLA-B7/beta-2 microglobulin plasmid DNA/lipid complex (Allovectin-7) in patients with metastatic melanoma.
Bergen M; Chen R; Gonzalez R
Expert Opin Biol Ther; 2003 Apr; 3(2):377-84. PubMed ID: 12662150
[TBL] [Abstract][Full Text] [Related]
10. Plasmid DNA malaria vaccine: tissue distribution and safety studies in mice and rabbits.
Parker SE; Borellini F; Wenk ML; Hobart P; Hoffman SL; Hedstrom R; Le T; Norman JA
Hum Gene Ther; 1999 Mar; 10(5):741-58. PubMed ID: 10210142
[TBL] [Abstract][Full Text] [Related]
11. Preclinical pharmacokinetics, manufacturing, and safety studies supporting a multicenter cancer gene therapy trial.
Norman JA; Parker S; Lew D; Manthorpe M; Marquet M
Hum Gene Ther; 1995 May; 6(5):549-50. PubMed ID: 7578391
[No Abstract] [Full Text] [Related]
12. Intratumoral interleukin 2 for renal-cell carcinoma by direct gene transfer of a plasmid DNA/DMRIE/DOPE lipid complex.
Hoffman DM; Figlin RA
World J Urol; 2000 Apr; 18(2):152-6. PubMed ID: 10854152
[TBL] [Abstract][Full Text] [Related]
13. Major histocompatibility gene therapy: the importance of haplotype and beta 2-microglobulin.
Salamone FN; Gleich LL; Li YQ; Stambrook PJ
Laryngoscope; 2004 Apr; 114(4):612-5. PubMed ID: 15064612
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of the acute toxicities induced by systemic administration of cationic lipid:plasmid DNA complexes in mice.
Tousignant JD; Gates AL; Ingram LA; Johnson CL; Nietupski JB; Cheng SH; Eastman SJ; Scheule RK
Hum Gene Ther; 2000 Dec; 11(18):2493-513. PubMed ID: 11119421
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of direct intralesional gene transfer of allovectin-7, an HLA-B7/beta2-microglobulin DNA-liposome complex, in patients with metastatic melanoma.
Stopeck AT; Jones A; Hersh EM; Thompson JA; Finucane DM; Gutheil JC; Gonzalez R
Clin Cancer Res; 2001 Aug; 7(8):2285-91. PubMed ID: 11489803
[TBL] [Abstract][Full Text] [Related]
16. Safety of interleukin-12 gene therapy against cancer: a murine biodistribution and toxicity study.
Imboden M; Shi F; Pugh TD; Freud AG; Thom NJ; Hank JA; Hao Z; Staelin ST; Sondel PM; Mahvi DM
Hum Gene Ther; 2003 Jul; 14(11):1037-48. PubMed ID: 12885344
[TBL] [Abstract][Full Text] [Related]
17. Locoregional response and increased natural killer activity after intratumoral injection of HLA-B7/beta2-microglobulin gene in patients with cancer.
Heo DS; Yoon SJ; Kim WS; Lee KH; Seol JG; Lee SG; Jung CW; Cho EK; Kim CW; Park MH; Sung MW; Kim KH; Bang YJ; Kim NK
Hum Gene Ther; 1998 Sep; 9(14):2031-8. PubMed ID: 9759930
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy for head and neck cancer.
Gleich LL
Laryngoscope; 2000 May; 110(5 Pt 1):708-26. PubMed ID: 10807351
[TBL] [Abstract][Full Text] [Related]
19. Response to the points to consider for immunotherapy of malignancy by in vivo gene transfer into tumors.
Hum Gene Ther; 1992 Dec; 3(6):705-11. PubMed ID: 1482710
[No Abstract] [Full Text] [Related]
20. Safety evaluation of hemagglutinating virus of Japan--artificial viral envelope liposomes in nonhuman primates.
Tsuboniwa N; Morishita R; Hirano T; Fujimoto J; Furukawa S; Kikumori M; Okuyama A; Kaneda Y
Hum Gene Ther; 2001 Mar; 12(5):469-87. PubMed ID: 11268281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
